Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is an X-linked, recessive, lysosomal storage disorder caused by deficiency of iduronate-2-sulfatase. It has multisystemic involvement, with manifestations in the brain, upper respiratory tract, heart, abdomen, joints and bones. Bone involvement...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulze-Frenking, G., Jones, Simon A., Roberts, J., Beck, M., Wraith, J. E.
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026660/
https://www.ncbi.nlm.nih.gov/pubmed/20978944
http://dx.doi.org/10.1007/s10545-010-9215-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026660/
https://www.ncbi.nlm.nih.gov/pubmed/20978944
http://dx.doi.org/10.1007/s10545-010-9215-2

Ejemplares similares